FDAFDA · Food and drugs·Recall number D-0060-2023
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Published November 23, 2022 · Recall initiated: November 9, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- ImprimisRx NJ
- Distributor
- Nationwide in the USA
- Lot
- Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.